Zobrazeno 1 - 10
of 54
pro vyhledávání: '"YOSUKE ICHIMIYA"'
Autor:
MOTO NISHIGUCHI, TOSHIKI TAKAYAMA, KOJI KASANUKI, TSUNEYOSHI OTA, NOBUTO SHIBATA, YOSUKE ICHIMIYA, HEII ARAI
Publikováno v:
Juntendo Medical Journal. 68:505-512
Autor:
Daisuke Asaoka, Jinzhong Xiao, Tsutomu Takeda, Naotake Yanagisawa, Takahiro Yamazaki, Yoichiro Matsubara, Hideki Sugiyama, Noemi Endo, Motoyuki Higa, Koji Kasanuki, Yosuke Ichimiya, Shigeo Koido, Kazuya Ohno, Francois Bernier, Noriko Katsumata, Akihito Nagahara, Heii Arai, Toshifumi Ohkusa, Nobuhiro Sato
Publikováno v:
Journal of Alzheimer's disease : JAD. 88(1)
Background: Probiotics have been reported to ameliorate cognitive impairment. Objective: We investigated the effect of the probiotic strain Bifidobacterium breve MCC1274 (A1) in enhancing cognition and preventing brain atrophy of older patients with
Autor:
Yosuke Ichimiya
Publikováno v:
Juntendo Medical Journal. 67:441-444
Autor:
Koji Kasanuki, Moto Nishiguchi, Mikiko Hagiwara, Shuntaro Natsume, Narimasa Katsuta, Yosuke Ichimiya, Kiyoshi Sato
Publikováno v:
Bipolar disordersREFERENCES. 24(6)
Autor:
Ryo Kumagai, Yosuke Ichimiya
Publikováno v:
Psychiatry and Clinical Neurosciences. 74:670-671
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 44:358-365
Purpose Evidence for the prodromal stage of dementia with Lewy bodies (DLB) is very limited. To address this issue, we investigate the 123I-FP-CIT SPECT measure of dopamine transporter binding finding and its clinical relevance.
Publikováno v:
Psychogeriatrics. 16:247-254
Aims Previous studies have suggested that insulin-like growth factor-I (IGF-I) deficiency may lead to cognitive deficits in neurodegenerative diseases such as Alzheimer's disease. The present study aimed to investigate the possible relationship betwe
Autor:
Eizo Iseki, Kazuo Umemura, Ko Eto, Yosuke Ichimiya, Koichi Miyakawa, Shinichi Tsuchiwata, Heii Arai, Nobuto Shibata, Hajime Baba, Eiji Kirino
Publikováno v:
Geriatrics & Gerontology International. 16:644-650
Aim To evaluate the safety, tolerability and pharmacokinetic profile of bapineuzumab after a single intravenous injection in Japanese patients with mild to moderate Alzheimer's disease. Methods Participants received either a placebo (n = 8), or bapin
Autor:
Yosuke Ichimiya, Yoichiro Matsubara
Publikováno v:
Alzheimer's & Dementia. 13
Publikováno v:
Alzheimer's & Dementia. 13